Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,692 | 311 | 99.4% |
| Education | $45.25 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,098 | 98 | $0 (2024) |
| Gilead Sciences, Inc. | $972.99 | 29 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $971.92 | 52 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $359.86 | 24 | $0 (2024) |
| Madrigal Pharmaceuticals | $352.59 | 9 | $0 (2024) |
| Fresenius Kabi USA, LLC | $346.80 | 4 | $0 (2023) |
| Lilly USA, LLC | $296.54 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $282.96 | 16 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $279.42 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $210.38 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,720 | 112 | ABBVIE INC. ($418.91) |
| 2023 | $2,523 | 95 | ABBVIE INC. ($538.71) |
| 2022 | $1,991 | 87 | ABBVIE INC. ($881.31) |
| 2021 | $503.48 | 19 | AbbVie Inc. ($258.60) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: LIVER DISEASE | ||||||
| 12/16/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Rare Disease | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $122.40 | General |
| Category: INFLAM | ||||||
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $2.65 | General |
| 12/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $5.32 | General |
| Category: LIVER DISEASE | ||||||
| 12/03/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $118.06 | General |
| Category: LIVER DISEASE | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: LIVER DISEASE | ||||||
| 11/20/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $26.93 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.03 | General |
| 11/07/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/06/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: LIVER DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 193 | 240 | $36,413 | $13,904 |
| 2022 | 7 | 206 | 265 | $33,507 | $14,120 |
| 2021 | 1 | 19 | 19 | $2,128 | $1,103 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 150 | $16,800 | $7,779 | 46.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $9,153 | $3,215 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 24 | $3,984 | $1,678 | 42.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,226 | $909.87 | 40.9% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 17 | 17 | $4,250 | $321.13 | 7.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 144 | $16,128 | $7,675 | 47.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $4,956 | $1,730 | 34.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $3,855 | $1,470 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 19 | $3,154 | $1,161 | 36.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 25 | $2,975 | $1,135 | 38.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 23 | $1,702 | $570.84 | 33.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $737.00 | $378.99 | 51.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 19 | $2,128 | $1,103 | 51.8% |
About Sarah Rooker
Sarah Rooker is a Nurse Practitioner healthcare provider based in Wichita, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2021. The National Provider Identifier (NPI) number assigned to this provider is 1013685494.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Rooker has received a total of $7,738 in payments from pharmaceutical and medical device companies, with $2,720 received in 2024. These payments were reported across 313 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($7,692).
As a Medicare-enrolled provider, Rooker has provided services to 418 Medicare beneficiaries, totaling 524 services with total Medicare billing of $29,127. Data is available for 3 years (2021–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Wichita, KS
- Active Since 09/01/2021
- Last Updated 06/21/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1013685494
Products in Payments
- XIFAXAN (Drug) $803.43
- SKYRIZI (Biological) $508.77
- RINVOQ (Biological) $485.08
- ZEPOSIA (Drug) $377.86
- MAVYRET (Drug) $368.20
- Epclusa (Drug) $350.26
- LINZESS (Drug) $329.74
- ENTYVIO (Biological) $321.07
- IDACIO (Biological) $314.77
- OCALIVA (Drug) $279.42
- OMVOH (Drug) $262.26
- REZDIFFRA (Drug) $248.56
- DUPIXENT (Biological) $231.52
- STELARA (Biological) $216.20
- TRULANCE (Drug) $168.49
- VOQUEZNA (Drug) $158.39
- CREON (Drug) $150.43
- TERLIVAZ (Drug) $147.95
- TREMFYA (Drug) $145.09
- SUCRAID (Drug) $135.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Wichita
Ms. Catherine Woods, Aprn, APRN
Nurse Practitioner — Payments: $49,709
Kristin Miller, Aprn, APRN
Nurse Practitioner — Payments: $44,574
Darine Jamaleddine, Aprn, APRN
Nurse Practitioner — Payments: $13,944
Christina Stanton, Aprn, APRN
Nurse Practitioner — Payments: $8,328
Amanda Mogoi, Aprn, APRN
Nurse Practitioner — Payments: $7,931
Constance Jacob, Aprn, APRN
Nurse Practitioner — Payments: $7,914